Daehan Nupharm Co.,Ltd.

₩5,010As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:054670Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (11.98%)
Div yield 2.00%
ROE 17.36%
Pharmaceutical Preparations
Beta (5Y) 0.17
PE TTM 2.938
TSR TTM (22.46%)
Mkt cap ₩70.32B
ROIC 4.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,016
20.07%
21.41%
Sell 1|8|1|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
88.22
88.60
93.88
93.30
12.82%
7.72%
12.17%
7.26%
Revenue₩B
6.913
6.992
7.379
7.436
7.23%
4.92%
5.92%
6.50%
Peers (US$51.84M)
Cap (US$)
PE
46.94M
—
52.57M
21.04x
Capital
TTM
5Y
10Y
Leveragex
1.041
0.513
0.455
EBIT/Intx
0.378
0.351
0.315
Own earn%
(12.97)
258.95
196.61
Sh yield%
36.52
36.51
41.84
Owners
Insiders/Inst%
3.42
77.35
Short interest%
4.81
SBC / revenue%
1.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
19–25
$1 testx
0.0
Incr. ROIC%
−1